We are live on ! Find out more
PCM

Perkins Capital Management Portfolio holdings

AUM $133M
1-Year Est. Return 127.86%
This Fund
S&P 500
This Quarter Est. Return
+7.42%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$176M
AUM Growth
+$3.3M
Cap. Flow
-$3.52M
Cap. Flow %
-2%
Top 10 Hldgs %
34.97%
Holding
113
New
8
Increased
24
Reduced
32
Closed
7

Top Buys

Rank Stock Value
1
SRXH
SRX Global
SRXH
+$1.26M
2
ACHV icon
Achieve Life Sciences
ACHV
+$1.25M
3
BIOL
Biolase, Inc.
BIOL
+$1.09M
4
VVOS icon
Vivos Therapeutics
VVOS
+$1.06M
5
ASPU
ASPEN GROUP, INC.
ASPU
+$1M

Top Sells

Rank Stock Value
1
VCEL icon
Vericel Corp
VCEL
+$4.36M
2
BIOR
Biora Therapeutics, Inc. Common Stock
BIOR
+$1.92M
3
SHSP
SharpSpring, Inc.
SHSP
+$1.79M
4
SONM icon
DNA X Inc
SONM
+$1.49M
5
INTZ
INTRUSION INC NEW
INTZ
+$1.4M

Sector Composition

Rank Sector Weight
1 Healthcare 61.83%
2 Technology 15.72%
3 Communication Services 6.71%
4 Industrials 4.61%
5 Consumer Staples 4.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANIP icon
76
ANI Pharmaceuticals
ANIP
$1.8B
$493K 0.28%
14,076
-590
-4% -$20.1K
OPCH icon
77
Option Care Health
OPCH
$3.45B
$492K 0.28%
22,500
– –
GIS icon
78
General Mills
GIS
$19.1B
$471K 0.27%
7,725
-114
-1% -$7.05K
FBIO icon
79
Fortress Biotech
FBIO
$104M
$460K 0.26%
8,587
+98
+1% +$5.91K
IMBI
80
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$451K 0.26%
56,000
– –
CVS icon
81
CVS Health
CVS
$133B
$447K 0.25%
5,359
– –
IRIX icon
82
IRIDEX
IRIX
$14.3M
$439K 0.25%
62,246
-10,000
-14% -$76K
JNJ icon
83
Johnson & Johnson
JNJ
$618B
$379K 0.22%
2,300
– –
CTEK
84
DELISTED
CynergisTek, Inc.
CTEK
$376K 0.21%
185,000
– –
ASUR icon
85
Asure Software
ASUR
$232M
$373K 0.21%
42,000
– –
BAX icon
86
Baxter International
BAX
$13.5B
$352K 0.2%
4,367
– –
AIRG icon
87
Airgain
AIRG
$73.4M
$340K 0.19%
16,500
– –
MDT icon
88
Medtronic
MDT
$109B
$323K 0.18%
2,600
– –
MYGN icon
89
Myriad Genetics
MYGN
$270M
$214K 0.12%
7,000
– –
VFF icon
90
Village Farms International
VFF
$234M
$214K 0.12%
+20,000
New +$211K
DYAI icon
91
Dyadic International
DYAI
$38.3M
$173K 0.1%
48,300
+600
+1% +$2.51K
LUMN icon
92
Lumen
LUMN
$6.57B
$173K 0.1%
+12,700
New +$175K
VRAY
93
DELISTED
ViewRay, Inc.
VRAY
$168K 0.1%
25,500
– –
VTRS icon
94
Viatris
VTRS
$20.4B
$151K 0.09%
10,546
– –
POWW icon
95
Outdoor Holding Co
POWW
$249M
$147K 0.08%
15,000
– –
ECOR icon
96
electroCore
ECOR
$54.8M
$119K 0.07%
+6,673
New +$172K
SIEN
97
DELISTED
Sientra, Inc.
SIEN
$107K 0.06%
1,350
– –
AIXC
98
AIxCrypto Holdings Inc
AIXC
$13.4M
$106K 0.06%
107
+44
+70% +$44.6K
FLXN
99
DELISTED
Flexion Therapeutics, Inc.
FLXN
$89K 0.05%
+10,800
New +$91.8K
AMRN
100
Amarin Corp
AMRN
$299M
$82K 0.05%
935
+100
+12% +$9.82K
1 2 3
4
5

Similar funds

SVP
Strategic Value Partners Greenwich, Connecticut $133M AUM
PWP
Phillips Wealth Planners Starkville, Mississippi $133M AUM 20.41% 1-Year Est. Return
BF
Bonfire Financial Colorado Springs, Colorado $133M AUM 12.09% 1-Year Est. Return
SFG
Synergy Financial Group San Ramon, California $133M AUM 22.16% 1-Year Est. Return
HWMG
Harbour Wealth Management Group Daniel Island, South Carolina $133M AUM
FTEA
Forty-three Eighteen Advisors Bentonville, Arkansas $133M AUM
WT
WHI Trust Chicago, Illinois $133M AUM
BAM
Brickwood Asset Management London, United Kingdom $133M AUM 10.27% 1-Year Est. Return

Perkins Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Perkins Capital Management held 113 positions worth $176M, up 1.9% from $173M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Perkins Capital Management's Q2 2021 filing shows 8 new, 24 increased, 32 reduced and 7 closed positions. Its largest new stake was SRX Global: 153 shares worth $1.29M. The largest sale was Vericel Corp, an estimated $4.36M.

By sector, the portfolio is most concentrated in Healthcare at 62% of assets, down from 63% a quarter earlier, followed by Technology and Communication Services.

  • Perkins Capital Management's largest Q2 2021 buy was SRX Global: 153 shares worth $1.29M.
  • Perkins Capital Management added most to Achieve Life Sciences in Q2 2021, an estimated $1.25M increase.
  • Perkins Capital Management's biggest Q2 2021 reduction was Vericel Corp, cutting an estimated $4.36M.
  • Perkins Capital Management fully exited Biora Therapeutics, Inc. Common Stock in Q2 2021, selling an estimated $1.92M.
  • Perkins Capital Management's ten largest holdings make up 35% of its $176M portfolio in Q2 2021.
  • Perkins Capital Management opened 8 new positions and closed 7 in Q2 2021.
  • Perkins Capital Management's portfolio value rose 1.9% quarter-over-quarter to $176M.

Based on Perkins Capital Management's 13F filing for Q2 2021, filed 28 Jul 2021.